@SassyCell

The growing inaccessibility of science that you can understand by paying €27.99

What is CRI's Clinical Trial Finder, and how does it work? Understand why clinical trials matter, and discover how you or your loved ones can utilize this free tool to create a path toward possibility: bit.ly/4tXh0Z5 #ClinicalTrial #Immunotherapy

From professional development sessions to methods workshops and more, #AACR26 has something for everyone. Program Committee Chairs Paul S. Mischel and Alice T. Shaw share Friday's highlights in AACR Annual Meeting News: brnw.ch/21x1H2k

Phase II Study of Anti-PD-1/​VEGF Bispecific Antibody Ivonescimab in Patients W/ Previously Treated Metastatic Colorectal Cancer @MDAndersonNews PI: Saurav Haldar, MD NCT06959550, 90 pts trial recruiting date advanced from October 2025 to open up "early" in July 25 @SassyCell

Introducing @ASCO Early-Onset/AYA Cancers Community of Practice, official twitter handle and logo. Please consider joining our CoP to advance care-delivery, research & education for pts with cancer in the EO/AYA groups. Looking forward to connecting with the community here on X!

@AnwaarSaeed3 presented DSP107 is a 1st in class T-cell engager with very promising activity in combo w/#immunotherapy including liver mets. #colorectalcancer #cancerresearch #cancer

🧬 Get ready for the latest in #colorectalcancer research! On June 10 at 11 AM EST, join us for Research Updates from ASCO 2025. Dr. Smitha Krishnamurthi and Annie Delores will break down the most exciting breakthroughs in CRC care. #ASCO25 Register to... fightcrc.zoom.us/webinar/regist…

Science tikkun: a bioscience pandemic framework in a Hebrew tradition of global repair | Molecular Medicine link.springer.com/article/10.118…

It’s podcast launch day! The ImmunoVerse™️ is now streaming on all your favorite platforms! 🚀 I’m honored to kick off this new @MoffittNews podcast with the inaugural episode ft. Dr. Steven Rosenberg, my colleague, friend, mentor and Chief of the Surgery Branch @theNCI. In episode 1, we explore Dr. Rosenberg’s pioneering work in immunotherapy, how far it has come, and where it’s headed! #TheImmunoVerse 🎙️ Listen now: Moffitt.org/ImmunoVerse

Do you know an up-and-coming expert in the field of cancer #immunotherapy? Nominate them today for SITC’s Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists. Learn more: sitcancer.org/Rosenberg-scho… #SITCForwardFund

🚨 URGENT: The President's 2026 Budget Proposal slashes cancer research and eliminates colorectal cancer screening programs. A proposed $18 BILLION CUT to NIH and elimination of the CDC's Colorectal Cancer Control Program puts lives at risk — especially in underserved communities that rely on access to screening and research-based care. But this isn't final — Congress controls the budget. Your voice matters. 📣 Take action now to protect these critical programs! fightcolorectalcancer.org/advocacy/publi…

Colorectal cancer is on the rise among young adults, @UCSanDiego describes. New research has uncovered that DNA mutations arising during early childhood from a bacterial toxin called colibactin are a potential cause. Learn more: bit.ly/4lHv1GV #ColorectalCancer

Colorectal cancer doesn’t just impact one person—it affects everyone who loves them. That’s why this year, we’re inviting teams to apply for our Ambassador Program. Whether you're family, partners, or friends who’ve stood together through the fight, we want to hear your shared story. Apply now and become a united force for awareness, advocacy, and change. 💙 🔗: fightcolorectalcancer.org/stories/ambass…

@PblSanchis Qué grande, con el termo y el mate! 🧉☺️

The future is bright thanks to your tireless work to improve patients' life! Great to meet you again, Katie! #CancerResearch #PatientAdvocacy #AACR25

At yesterday's opening ceremony, we asked the cancer community to stand together to make their voices heard in support of innovative cancer science and medicine. #CancerResearchSavesLives® #AACR25

Congratulations to our team. Next chapter in Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine nejm.org/doi/10.1056/NE…

These are the faces of cancer advocacy. TY @AACR for creating programs & enabling opportunities for us to be here & be on the main stage of sessions. Cancer research saves lives when we all work together! #AACR25 @coffeemommy @jillfeldman4 @bobriter @coloncancergal @manjuggm

It's not only uncovering what is causing young-adult cases, but also how we can devise better ways to treat it. At today's #AACR25 session on Innovative Approaches to Key Molecular Targets, I will present work targeting a novel intracellular immune checkpoint using cell therapy.

@FDAOncology @FightCRC

FDA approves a treatment for patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer fda.gov/drugs/resource…